![Douglas Stockdale](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Douglas Stockdale
Direttore operativo presso Hillhurst Biopharmaceuticals, Inc.
Posizioni attive di Douglas Stockdale
Società | Posizione | Inizio | Fine |
---|---|---|---|
Hillhurst Biopharmaceuticals, Inc.
![]() Hillhurst Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Hillhurst Biopharmaceuticals, Inc. is a private company that specializes in developing a gas in liquid advanced stability system called Hillhurst's proprietary GLASSTM platform. The company is based in San Diego, CA. This platform enables novel uses of therapeutic gases that were previously limited by inhaled delivery. The company has developed a unique pipeline of novel liquid therapeutic candidates intended to treat patients with sickle cell disease, Parkinson's disease, and acute pain. The company was founded by Edward Gomperts. The CEO is Andrew Gomperts. | Direttore operativo | - | - |
Direttore Tecnico/Scientifico/R&S | - | - |
Storia della carriera di Douglas Stockdale
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Posizioni
Chief Operating Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Hillhurst Biopharmaceuticals, Inc.
![]() Hillhurst Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Hillhurst Biopharmaceuticals, Inc. is a private company that specializes in developing a gas in liquid advanced stability system called Hillhurst's proprietary GLASSTM platform. The company is based in San Diego, CA. This platform enables novel uses of therapeutic gases that were previously limited by inhaled delivery. The company has developed a unique pipeline of novel liquid therapeutic candidates intended to treat patients with sickle cell disease, Parkinson's disease, and acute pain. The company was founded by Edward Gomperts. The CEO is Andrew Gomperts. | Health Technology |
- Borsa valori
- Insiders
- Douglas Stockdale
- Esperienza